Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial
Delveinsight
JULY 27, 2021
Cognito Therapeutics located in Cambridge is a clinical-stage company developing novel digital therapeutics that presented clinical data on gamma frequency neuro-modulation on cognitive function from its lead digital therapeutic candidate in AD. The study was based upon reduction in brain atrophy induced from gamma frequency neuro-modulation.
Let's personalize your content